Yvonne Hui Sells 465 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR - Get Free Report) insider Yvonne Hui sold 465 shares of the business's stock in a transaction that occurred on Thursday, July 17th. The shares were sold at an average price of $26.89, for a total value of $12,503.85. Following the sale, the insider owned 29,816 shares of the company's stock, valued at approximately $801,752.24. This represents a 1.54% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Yvonne Hui also recently made the following trade(s):

• On Friday, July 18th, Yvonne Hui sold 626 shares of Phreesia stock. The stock was sold at an average price of $26.23, for a total value of $16,419.98.
• On Wednesday, July 16th, Yvonne Hui sold 422 shares of Phreesia stock. The shares were sold at an average price of $26.95, for a total value of $11,372.90.
• On Tuesday, July 15th, Yvonne Hui sold 307 shares of Phreesia stock. The stock was sold at an average price of $27.27, for a total value of $8,371.89.
• On Monday, July 7th, Yvonne Hui sold 571 shares of Phreesia stock. The shares were sold at an average price of $28.85, for a total value of $16,473.35.
• On Tuesday, June 10th, Yvonne Hui sold 582 shares of Phreesia stock. The stock was sold at an average price of $28.00, for a total value of $16,296.00.

Phreesia Stock Up 4.0%

Shares of NYSE:PHR traded up $1.03 during midday trading on Monday, hitting $26.51. 597,110 shares of the company's stock traded hands, compared to its average volume of 456,444. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.95 and a current ratio of 1.95. The company has a market cap of $1.58 billion, a PE ratio of -35.82 and a beta of 0.72. The firm's fifty day moving average price is $26.50 and its two-hundred day moving average price is $26.41. Phreesia, Inc. has a twelve month low of $17.07 and a twelve month high of $30.53.

Phreesia (NYSE:PHR - Get Free Report) last issued its quarterly earnings data on Wednesday, May 28th. The company reported ($0.07) EPS for the quarter, topping analysts' consensus estimates of ($0.13) by $0.06. The firm had revenue of $115.94 million for the quarter, compared to analyst estimates of $115.00 million. Phreesia had a negative net margin of 9.83% and a negative return on equity of 16.23%. The firm's revenue was up 14.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($0.05) EPS. On average, equities research analysts anticipate that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Analyst Ratings Changes

Several research analysts have weighed in on the company. DA Davidson dropped their price target on Phreesia from $36.00 to $34.00 and set a "buy" rating for the company in a research note on Monday, April 14th. Wall Street Zen raised shares of Phreesia from a "hold" rating to a "buy" rating in a report on Sunday, June 1st. Citigroup reaffirmed a "buy" rating on shares of Phreesia in a report on Wednesday, May 28th. Canaccord Genuity Group cut their price objective on shares of Phreesia from $35.00 to $34.00 and set a "buy" rating for the company in a report on Thursday, May 29th. Finally, Truist Financial increased their price objective on shares of Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a report on Thursday, May 29th. Twelve equities research analysts have rated the stock with a buy rating, According to MarketBeat, the company presently has an average rating of "Buy" and a consensus price target of $32.27.

Hedge Funds Weigh In On Phreesia

Several institutional investors and hedge funds have recently modified their holdings of PHR. Vanguard Group Inc. increased its position in Phreesia by 2.4% during the 1st quarter. Vanguard Group Inc. now owns 4,936,515 shares of the company's stock valued at $126,177,000 after purchasing an additional 113,405 shares during the period. Greenhouse Funds LLLP increased its position in Phreesia by 2.9% during the 1st quarter. Greenhouse Funds LLLP now owns 2,956,910 shares of the company's stock valued at $75,579,000 after purchasing an additional 83,018 shares during the period. Champlain Investment Partners LLC grew its position in shares of Phreesia by 20.0% during the 1st quarter. Champlain Investment Partners LLC now owns 2,946,489 shares of the company's stock worth $75,312,000 after buying an additional 490,340 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in shares of Phreesia by 108.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,644,988 shares of the company's stock worth $67,606,000 after buying an additional 1,377,904 shares during the period. Finally, Franklin Resources Inc. grew its position in shares of Phreesia by 0.8% during the 4th quarter. Franklin Resources Inc. now owns 1,509,617 shares of the company's stock worth $37,982,000 after buying an additional 11,986 shares during the period. 92.10% of the stock is currently owned by institutional investors and hedge funds.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.